Thursday, November 17, 2011

Sanofi's Multaq will no longer be reimbursed in France | Reuters

Nov 16 (Reuters) - Sanofi's irregular heart beat drug Multaq will no longer be reimbursed by the French health system from December, in a further setback to a medicine once seen as a blockbuster product.

The decision follows a July recommendation by France's top medical authority, the Haute Autorite de Sante, that Multaq should be withdrawn from the list of drugs reimbursed by the state-run health system.

HAS said at the time Multaq, known chemically as dronedarone, was not sufficiently effective.

Reimbursement in France will stop from Dec. 1, 2011, according to a notice published in the government's official bulletin.

Posted via email from Jack's posterous

No comments: